Depression treatment for Boca Raton — measurement-based, 20 minutes away.

For Boca Raton clients from Mizner Park, Royal Palm Place, or Highland Beach, RECO Health's Delray Beach campus is a 20-minute drive up Federal Highway — close enough that PHP-level depression care fits into daily life without relocation. Every treatment plan is built on a DSM-5-TR formulation, tracked with PHQ-9 and C-SSRS, and includes in-house psychiatry, protocol-driven CBT, IPT, and Behavioral Activation, plus a pre-defined escalation pathway to rTMS or IV ketamine when two adequate antidepressant trials fail. Care is measurement-based, not impression-based.

From Mizner Park or Royal Palm Place, the drive up Federal Highway to RECO Health’s Delray Beach campus takes about twenty minutes — often shorter than a Boca commute to Fort Lauderdale. That geography matters clinically: partial hospitalization for depression only works when clients can sleep in their own bed, keep local family involvement, and return the next morning without dismantling their life. Our depression treatment program is built around that continuity, at PHP and IOP levels of care, with in-house psychiatry and a defined escalation pathway when standard care isn’t enough.

Diagnostic formulation and severity staging

Every admission begins with a structured DSM-5-TR evaluation. The initial psychiatric assessment distinguishes major depressive disorder from persistent depressive disorder, bipolar II depression, adjustment disorder with depressed mood, and depression secondary to a general medical condition or substance use — a distinction that determines whether an antidepressant, a mood stabilizer, or the taper of an offending agent is the right first step. The PHQ-9 anchors severity, the Columbia Suicide Severity Rating Scale (C-SSRS) documents active versus passive suicidal ideation with intent and plan, and the GAD-7 quantifies comorbid anxiety.

Baseline labs are drawn to rule out medical contributors: thyroid panel (TSH, free T4), B12, folate, vitamin D, and — where indicated — a metabolic panel and inflammatory markers. A meaningful minority of depression presentations turn out to be driven primarily by hypothyroidism, B12 deficiency, or untreated obstructive sleep apnea; treating the underlying cause is faster than any SSRI trial and prevents a fruitless medication chase.

Level of care matches severity, not intake capacity. PHP (six clinical hours per day, five days per week) is appropriate for severe presentations with PHQ-9 in the 15+ range or acute suicidal ideation and adequate outpatient support at home. IOP (three hours per day, three-to-five days per week) handles moderate presentations and step-downs from PHP.

Pharmacology sequenced by evidence, not habit

First-line pharmacotherapy is an SSRI — sertraline, escitalopram — or an SNRI — venlafaxine XR, duloxetine — titrated to therapeutic dose (sertraline 100–200 mg, escitalopram 10–20 mg, venlafaxine 150–225 mg) with four-to-six week response windows before judgment is called. Prescribing accounts for comorbidity: bupropion for prominent anergia or nicotine dependence, mirtazapine for insomnia and appetite loss, duloxetine when chronic pain is a driver.

Partial responders — PHQ-9 dropping but not below 10 — are augmented before switching. Second-generation antipsychotics carry FDA labeling for adjunctive use in MDD: aripiprazole 2–5 mg, quetiapine XR 150–300 mg, and the olanzapine-fluoxetine combination for MDD with mixed or anxious features. Lithium and T3 remain evidence-supported STAR*D augmentation options; bupropion added to an SSRI is common but off-label. Buspirone is used adjunctively when comorbid GAD dominates the picture. Every decision is documented alongside PHQ-9 trajectory, so a switch is a data call rather than a preference.

Treatment-resistant depression — two failed adequate trials at therapeutic dose and duration — is staged for interventional care rather than cycled through a fifth antidepressant.

Behavioral therapy delivered to protocol

Depression-specific psychotherapy is delivered to protocol, not as a loose collection of techniques. Cognitive Behavioral Therapy (CBT) for depression targets the cognitive distortions — catastrophizing, personalization, all-or-nothing thinking — that maintain low mood and the behavioral withdrawal that reinforces it, using structured thought records and behavioral experiments over a 12–16 session arc. Behavioral Activation is used stand-alone for clients whose depression presents primarily as anhedonia and shutdown, scheduling graded rewarding and mastery activities and monitoring mood response session-over-session.

Interpersonal Therapy (IPT) is deployed when the depression is anchored to grief, role transition (divorce, retirement, new parenthood), or a specific relational conflict. For clients with trauma-linked depression — a common presentation in adults with childhood adversity — Cognitive Processing Therapy (CPT) or EMDR is layered in once mood is stable enough to tolerate trauma processing.

Acceptance and Commitment Therapy (ACT) is used when depression is chronic and values-disconnected; Motivational Interviewing (MI) is threaded through when there’s ambivalence about medication adherence or lifestyle change. Dialectical Behavior Therapy skills — distress tolerance, emotion regulation — are added when self-harm or affective instability co-presents.

Escalation pathway for treatment-resistant depression

Roughly a third of clients with major depression will not achieve remission with two adequate antidepressant trials — the STAR*D findings on this are unflattering but stable, and the clinical protocol here is built around them rather than despite them. The escalation pathway is defined in advance rather than improvised after months of drift.

Repetitive transcranial magnetic stimulation (rTMS) is offered for insurance-eligible treatment-resistant depression: standard 10 Hz protocol over the left dorsolateral prefrontal cortex, 3000 pulses per session at 120% of resting motor threshold, 36 sessions over six-to-nine weeks. Real-world response rates in TRD samples run 50–60%, remission 30–40%.

IV ketamine (0.5 mg/kg over 40 minutes, six-infusion induction over two-to-three weeks) is the appropriate escalation when suicidality or functional collapse doesn’t allow the six weeks an SSRI switch would require; onset of effect within 24–72 hours is the point. Esketamine (Spravato) is offered where a REMS-monitored intranasal protocol and payer coverage make it the cleaner path.

What to expect on the first visit

The intake day begins with a 60–90 minute psychiatric evaluation, a psychosocial assessment, and — where a substance use history is present — an ASAM Criteria dimensional review across the six dimensions. Baseline PHQ-9, GAD-7, and C-SSRS are administered; labs are drawn or prior results reviewed. If the presentation includes anxiety or attention concerns, an ASRS or additional screening is added rather than deferred.

Boca Raton clients typically arrive at 8:30–9:00 AM at the Delray Beach campus and finish by 3:00 PM, which returns them home in time for school pickup or evening obligations. Therapist assignment is made based on presentation: trauma-linked depression is matched to a CPT- or EMDR-trained clinician, chronic anhedonia to a Behavioral Activation-trained clinician. Clients leave day one with a written treatment plan and a starting medication decision.

Insurance and admissions from Boca Raton

RECO Health is in-network with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS. PHP and IOP are covered as standard mental health benefits under most commercial PPO plans after deductible; the admissions team verifies benefits and out-of-pocket exposure within a business day. Interventional services — rTMS, IV ketamine, and Spravato — are billed and pre-authorized separately, since payer rules for TRD vary by carrier.

Admissions are usually scheduled within 48–72 hours of a first call. For clients from Mizner Park, Royal Palm Place, Downtown Boca, Boca West, or Highland Beach, the 20-minute drive up Federal Highway means no relocation, no hotel, and continuous involvement of local support systems throughout treatment.

Serving residents of: Mizner Park, Royal Palm Place, Downtown Boca, Boca West, Highland Beach.